Gsk (GSK) Return on Equity [ROE] (2009 - 2026)
Gsk (GSK) reported Return on Equity [ROE] of 62.56% for the quarter ended Jun 30, 2026.
Analysis
Gsk (GSK) Return on Equity [ROE] (2009 - 2026) Analysis & Trends
For the year ended Dec 31, 2025, Gsk posted Return on Equity [ROE] of 42.29%, up 20.20 percentage points from the prior year.
- Return on Equity [ROE] has a five-year change of +11.01 percentage points (years ended Dec 2020 to Dec 2025).
- By year, Return on Equity [ROE] came in at 22.09% in the year ended Dec 31, 2024 (-22.26 pp), 44.35% in the year ended Dec 31, 2023 (-48.63 pp), 92.98% in the year ended Dec 31, 2022 (+68.45 pp) and 24.53% in the year ended Dec 31, 2021 (-6.76 pp).
- The figure for the quarter ended Jun 30, 2026 ranks as the lowest quarterly Return on Equity [ROE] since the quarter ended Dec 31, 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | PetVivo Holdings | 3,096.39 Bn | 3,096.39 Bn | 196,075.00 | -1,456.09% |
| 2 | Eli Lilly | 1,202.70 Bn | 1,176.32 Bn | 20.46 Bn | 74.39% |
| 3 | Johnson & Johnson | 649.77 Bn | 569.63 Bn | 17.30 Bn | 19.33% |
| 4 | AbbVie | 507.00 Bn | 475.00 Bn | 13.12 Bn | - |
| 5 | Merck | 329.70 Bn | 292.64 Bn | 13.19 Bn | 5.63% |
| 6 | Novartis Ag | 291.91 Bn | 265.14 Bn | - | - |
| 7 | Amgen | 236.26 Bn | 187.91 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 207.15 Bn | 182.26 Bn | 6.73 Bn | -31.17% |
| 9 | Gsk | 193.54 Bn | 176.38 Bn | - | - |
| 10 | Pfizer | 156.44 Bn | 103.79 Bn | 12.56 Bn | 4.66% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 62.56% |
| Dec 31, 2025 | 67.50% |
| Dec 31, 2024 | 29.84% |
| Mar 31, 2024 | 35.54% |
| Dec 31, 2023 | 107.38% |
| Mar 31, 2023 | 134.42% |
| Dec 31, 2022 | 168.18% |
| Sep 30, 2022 | 97.00% |
| Jun 30, 2022 | 20.17% |
| Mar 31, 2022 | 23.94% |
| Dec 31, 2021 | 23.72% |
| Dec 31, 2020 | 27.28% |
| Dec 31, 2019 | 32.22% |
| Sep 30, 2019 | 51.31% |
| Dec 31, 2018 | 86.87% |
| Jun 30, 2018 | 66.62% |
| Dec 31, 2017 | 74.35% |
| Jun 30, 2017 | 35.99% |
| Dec 31, 2016 | 74.01% |
| Sep 30, 2016 | 211.43% |
API Access
Gsk Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=GSK&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "GSK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=GSK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();